Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
CN |
|
Golden Eagle Energy Tbk PT
IDX:SMMT
|
ID |
|
Pan Ocean Co Ltd
KRX:028670
|
KR |
|
E
|
Elanco Animal Health Inc
SWB:5EA
|
US |
|
COSCO Shipping Holdings Co Ltd
SSE:601919
|
CN |
|
Nexgel Inc
NASDAQ:NXGL
|
US |
|
C
|
Computer and Technologies Holdings Ltd
HKEX:46
|
HK |
|
S
|
Smithfield Foods Inc
NASDAQ:SFD
|
US |
|
P
|
Proud Real Estate PCL
SET:PROUD
|
TH |
|
V
|
Vox Royalty Corp
NASDAQ:VOXR
|
CA |
|
Original Juice Co Ltd
ASX:OJC
|
AU |
|
B
|
Berjaya Corporation Bhd
KLSE:BJCORP
|
MY |
|
Mortgage Service Japan Ltd
TSE:7192
|
JP |
|
ME Group International PLC
LSE:MEGP
|
UK |
|
B
|
BW Ideol AS
OSE:BWIDL
|
NO |
|
Ansarada Group Ltd
ASX:AND
|
AU |
|
Comefly Outdoor Co Ltd
SSE:603908
|
CN |
Wall Street
Price Targets
Price Targets Summary
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
According to Wall Street analysts, the average 1-year price target for
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
is 51 CNY
with a low forecast of 50.5 CNY and a high forecast of 52.5 CNY.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Beijing Wantai Biological Pharmacy Enterprise Co Ltd's stock price target?
Price Target
51
CNY
According to Wall Street analysts, the average 1-year price target for
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
is 51 CNY
with a low forecast of 50.5 CNY and a high forecast of 52.5 CNY.
What is Beijing Wantai Biological Pharmacy Enterprise Co Ltd's Revenue forecast?
Projected CAGR
7%
For the last 6 years the
compound annual growth rate for
Beijing Wantai Biological Pharmacy Enterprise Co Ltd's revenue is
15%.
The projected
CAGR
for the next 2 years is
7%.
What is Beijing Wantai Biological Pharmacy Enterprise Co Ltd's Net Income forecast?
Projected CAGR
-22%
For the last 6 years the
compound annual growth rate for
Beijing Wantai Biological Pharmacy Enterprise Co Ltd's net income is
-16%.
The projected
CAGR
for the next 2 years is
-22%.
